• Title of article

    miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells

  • Author/Authors

    Ujifuku، نويسنده , , Kenta and Mitsutake، نويسنده , , Norisato and Takakura، نويسنده , , Shu and Matsuse، نويسنده , , Michiko and Saenko، نويسنده , , Vladimir and Suzuki، نويسنده , , Keiji and Hayashi، نويسنده , , Kentaro and Matsuo، نويسنده , , Takayuki and Kamada، نويسنده , , Kensaku and Nagata، نويسنده , , Izumi and Yamashita، نويسنده , , Shunichi، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2010
  • Pages
    8
  • From page
    241
  • To page
    248
  • Abstract
    To identify microRNAs (miRNAs) specifically involved in the acquisition of temozolomide (TMZ) resistance in glioblastoma multiforme (GBM), we first established a resistant variant, U251R cells from TMZ-sensitive GBM cell line, U251MG. We then performed a comprehensive analysis of miRNA expressions in U251R and parental cells using miRNA microarrays. miR-195, miR-455-3p and miR-10a∗ were the three most up-regulated miRNAs in the resistant cells. To investigate the functional role of these miRNAs in TMZ resistance, U251R cells were transfected with miRNA inhibitors consisting of DNA/LNA hybrid oligonucleotides. Suppression of miR-455-3p or miR-10a∗ had no effect on cell growth, but showed modest cell killing effect in the presence of TMZ. On the other hand, knockdown of miR-195 alone displayed moderate cell killing effect, and combination with TMZ strongly enhanced the effect. In addition, using in silico analysis combined with cDNA microarray experiment, we present possible mRNA targets of these miRNAs. In conclusion, our findings suggest that those miRNAs may play a role in acquired TMZ resistance and could be a novel target for recurrent GBM treatment.
  • Keywords
    miR-10a? , Glioblastoma , Temozolomide , miR-455-3p , MicroRNA , resistance , miR-195
  • Journal title
    Cancer Letters
  • Serial Year
    2010
  • Journal title
    Cancer Letters
  • Record number

    1819110